California Public Employees Retirement System cut its stake in Corteva, Inc. (NYSE:CTVA – Free Report) by 0.7% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,345,578 shares of the company’s stock after selling 9,796 shares during the quarter. California Public Employees Retirement System’s holdings in Corteva were worth $112,638,000 as of its most recent filing with the Securities & Exchange Commission.
Other large investors also recently modified their holdings of the company. JPL Wealth Management LLC purchased a new position in shares of Corteva during the third quarter valued at approximately $25,000. Westfuller Advisors LLC raised its position in Corteva by 2,764.3% in the 1st quarter. Westfuller Advisors LLC now owns 401 shares of the company’s stock valued at $34,000 after buying an additional 387 shares during the last quarter. Garton & Associates Financial Advisors LLC bought a new position in Corteva during the 4th quarter valued at $27,000. Bank of Jackson Hole Trust bought a new position in Corteva during the 4th quarter valued at $28,000. Finally, Cornerstone Financial Management LLC purchased a new position in Corteva during the 4th quarter worth $29,000. Institutional investors own 81.54% of the company’s stock.
Corteva Stock Up 0.9%
CTVA stock opened at $87.42 on Friday. The stock has a market cap of $58.47 billion, a P/E ratio of 51.43, a P/E/G ratio of 2.67 and a beta of 0.56. The company has a current ratio of 1.47, a quick ratio of 1.03 and a debt-to-equity ratio of 0.07. The stock’s fifty day simple moving average is $80.86 and its two-hundred day simple moving average is $78.19. Corteva, Inc. has a 1-year low of $60.53 and a 1-year high of $88.22.
Corteva Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Monday, June 15th. Investors of record on Monday, June 1st were given a dividend of $0.18 per share. The ex-dividend date was Monday, June 1st. This represents a $0.72 annualized dividend and a yield of 0.8%. Corteva’s dividend payout ratio is presently 42.35%.
Analysts Set New Price Targets
Several analysts have recently issued reports on the stock. UBS Group reduced their target price on shares of Corteva from $90.00 to $86.00 and set a “neutral” rating for the company in a research note on Tuesday, June 9th. BNP Paribas Exane raised their price target on shares of Corteva from $74.00 to $77.00 in a research report on Wednesday, May 6th. CICC Research boosted their price target on shares of Corteva from $80.00 to $93.00 and gave the stock an “outperform” rating in a report on Wednesday, May 13th. Oppenheimer upped their price objective on shares of Corteva from $86.00 to $89.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 22nd. Finally, The Goldman Sachs Group increased their price objective on shares of Corteva from $88.00 to $96.00 and gave the company a “buy” rating in a research note on Tuesday, April 14th. One analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and eight have assigned a Hold rating to the company. According to data from MarketBeat, Corteva has a consensus rating of “Moderate Buy” and an average price target of $88.95.
Get Our Latest Research Report on Corteva
Corteva Profile
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Featured Articles
- Five stocks we like better than Corteva
- Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop
- Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs?
- The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story
- Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
